The report provides a comprehensive analysis of the potential of Global Respiratory Devices. The report covers an overview and genesis of the industry, market size in terms of revenue generated.
According to estimates, the Global Respiratory Devices market which grew at a robust CAGR from 2017-2022 & is forecasted to grow steadily from 2022-2027 driven by increase in respiratory illness cases, innovative technologies alongside growing inorganic growth strategies.
The rapid growth in global geriatric population, rising incidents of chronic diseases (including COPD & asthma), alongside the cost advantage of home care devices & services are the key factors driving the global respiratory devices market.
Infectious respiratory diseases directly drive demand for respiratory care. COVID-19 is the most recent example of these diseases. The pandemic has resulted in a surge for demand for personal protective equipment & ventilators, among others.
Key Trends by Market Segment
- By Product: Inhalers segment is expected to record highest CAGR in the upcoming years owing to rising cases of Asthma amongst younger generation as a result of Air Pollution.
- By End-User: Hospitals accounted for largest share of market in 2022 owing to growing public-private partnerships & improving healthcare infrastructure.
Competitive Landscape
The Global Respiratory Devices Market is fragmented with players occupying almost half of the market. The key players operating in the market are not only competing based on product quality and promotion but are also focusing on strategic moves to hold larger market shares. The major companies dominating the Global Respiratory Devices market for its products, services, and continuous product developments are the basis of flexibility and price, brand recognition, quality, and the overall variety of the product offering among others.
Future Outlook
The Global Respiratory Devices Market witnessed significant growth during the period 2017-2022, owing to increase in fast fashion trends, Enhancing Service Offerings alongside increase in product innovativeness. The growth rate of the market is going to increase over the period as market penetration rates increase.
Time Period Captured in the Report:
- Historical Period: 2017-2022
- Base Year: 2022
- Forecast Period: 2022-2027
Key Target Audience:
- Government
- Hospitals
- Clinics
- Others
Additional benefits of purchasing an enterprise license:
- TAM/SAM/SOM Analysis
- Customer Cohort Analysis
- Marketing Initiatives
- White Space Opportunity Analysis
- Interactive Data Visualizations
- Customization: 20 Analyst Hours
- 3 Months Post Sales Analyst Support
- Complimentary Update Next Year
- Custom Webinars
Table of Contents
1. Executive Summary
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Fisher & Paykel Healthcare Limited
- ICU Medical Inc.
- Medtronic
- Philips Healthcare
- ResMed
- Xplore Health Technologies Ltd.
